Literature DB >> 76413

Quantitation of human granulocyte protease inhibitors in non-purulent bronchial lavage fluids.

H Tegner.   

Abstract

The predominant inhibitors of granulocyte proteases in plasma (alpha1-antitrypsin, alpha1-antichymotrypsin, and alpha2-macroglobulin) were quantitated in unconcentrated bronchial lavage fluids obtained from non-infected individuals, together with the acid-stable low molecular weight inhibitor with activity against granulocyte elastolytic and chymotrypsin-like enzymes. This latter inhibitor accounted for about 90% of the total molar concentration of granulocyte protease inhibitors in the bronchial lavage fluids. The remaining 10% consisted mostly of alpha1-antitrypsin and alpha1-antichymotrypsin. About 85% of the bronchial inhibitor was in a free form with preserved enzyme reactivity. The remaining 15% of the immunoreactive bronchial inhibitor exhibited a molecular size indicating complexation with enzymes. The major portion of alpha1-antitrypsin and alpha1-antichymotrypsin showed electrophoretic mobilities and molecular sizes similar to the native proteins but had no enzyme reactivity.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 76413     DOI: 10.3109/00016487809111936

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  15 in total

Review 1.  Anti-inflammatory and antimicrobial roles of secretory leukocyte protease inhibitor.

Authors:  Stergios Doumas; Alexandros Kolokotronis; Panagiotis Stefanopoulos
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

Review 2.  Low-molecular-weight protease inhibitor of the respiratory tract.

Authors:  J A Kramps; C Franken
Journal:  Surv Immunol Res       Date:  1982

3.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage.

Authors:  G W Hunninghake; J E Gadek; O Kawanami; V J Ferrans; R G Crystal
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

4.  Stimulation of human leukocyte elastase by platelet factor 4. Physiologic, morphologic, and biochemical effects on hamster lungs in vitro.

Authors:  S A Lonky; H Wohl
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

5.  Decreased levels of secretory leucoprotease inhibitor in the Pseudomonas-infected cystic fibrosis lung are due to neutrophil elastase degradation.

Authors:  Sinéad Weldon; Paul McNally; Noel G McElvaney; J Stuart Elborn; Danny F McAuley; Julien Wartelle; Abderrazzaq Belaaouaj; Rodney L Levine; Clifford C Taggart
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

6.  A study of plasma proteins in the sol phase of sputum from patients with chronic bronchitis.

Authors:  R A Stockley; M Mistry; A R Bradwell; D Burnett
Journal:  Thorax       Date:  1979-12       Impact factor: 9.139

7.  Antielastases of the human alveolar structures. Implications for the protease-antiprotease theory of emphysema.

Authors:  J E Gadek; G A Fells; R L Zimmerman; S I Rennard; R G Crystal
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

8.  Protease-antiprotease levels and whole-blood chemiluminescence in acute peritonitis.

Authors:  M Bergenfeldt; K Ohlsson
Journal:  Gastroenterol Jpn       Date:  1993-10

9.  Lung secretion sol-phase proteins: comparison of sputum with secretions obtained by direct sampling.

Authors:  J Wiggins; S L Hill; R A Stockley
Journal:  Thorax       Date:  1983-02       Impact factor: 9.139

10.  Serum and sputum alpha 2 macroglobulin in patients with chronic obstructive airways disease.

Authors:  D Burnett; R A Stockley
Journal:  Thorax       Date:  1981-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.